PEXEVA Drug Patent Profile
✉ Email this page to a colleague
When do Pexeva patents expire, and when can generic versions of Pexeva launch?
Pexeva is a drug marketed by Sebela Ireland Ltd and is included in one NDA. There is one patent protecting this drug.
This drug has forty patent family members in twenty-five countries.
The generic ingredient in PEXEVA is paroxetine mesylate. There are thirty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the paroxetine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pexeva
A generic version of PEXEVA was approved as paroxetine mesylate by ACTAVIS LABS FL INC on June 20th, 2017.
Summary for PEXEVA
International Patents: | 40 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Clinical Trials: | 1 |
Patent Applications: | 195 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PEXEVA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PEXEVA |
What excipients (inactive ingredients) are in PEXEVA? | PEXEVA excipients list |
DailyMed Link: | PEXEVA at DailyMed |



Recent Clinical Trials for PEXEVA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Central Michigan University | N/A |
Sheppard Pratt Health System | N/A |
Pharmacology for PEXEVA
Drug Class | Serotonin Reuptake Inhibitor |
Mechanism of Action | Serotonin Uptake Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for PEXEVA
US Patents and Regulatory Information for PEXEVA
PEXEVA is protected by one US patents.
Patents protecting PEXEVA
Crystalline paroxetine methane sulfonate
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-001 | Jul 3, 2003 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-004 | Jul 3, 2003 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-002 | Jul 3, 2003 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-003 | Jul 3, 2003 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PEXEVA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-004 | Jul 3, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-004 | Jul 3, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-001 | Jul 3, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-002 | Jul 3, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-003 | Jul 3, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-003 | Jul 3, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PEXEVA
See the table below for patents covering PEXEVA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 100543614 | ⤷ Try a Trial | |
Bulgaria | 64315 | ⤷ Try a Trial | |
European Patent Office | 1078925 | ⤷ Try a Trial | |
Czech Republic | 295301 | Deriváty 4-fenylpiperidinu, způsob jejich přípravy, jejich použití a lék je obsahující (4-Phenylpiperidine derivatives, process of their preparation, their use and medicament in which the derivatives are comprised) | ⤷ Try a Trial |
Iceland | 7098 | ⤷ Try a Trial | |
Estonia | 9900570 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |